PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PTC Therapeutics Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Other Current Liabilities
$137.3m
CAGR 3-Years
16%
CAGR 5-Years
36%
CAGR 10-Years
92%
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.2B
CAGR 3-Years
95%
CAGR 5-Years
282%
CAGR 10-Years
29%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$279.3m
CAGR 3-Years
7%
CAGR 5-Years
33%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$586m
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
24%

See Also

What is PTC Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
137.3m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Other Current Liabilities amounts to 137.3m USD.

What is PTC Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
92%

Over the last year, the Other Current Liabilities growth was -20%. The average annual Other Current Liabilities growth rates for PTC Therapeutics Inc have been 16% over the past three years , 36% over the past five years , and 92% over the past ten years .

Back to Top